Stock ADAP ADAPTIMMUNE THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

News Adaptimmune Therapeutics plc

Equities

ADAP

US00653A1079

Real-time Estimate Cboe BZX
Other stock markets
 03:48:21 2024-04-19 pm EDT 		5-day change 1st Jan Change
0.974 USD +8.41% Intraday chart for Adaptimmune Therapeutics plc -16.72% +21.82%
05:11pm European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down MT
Apr. 18 European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
MT
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
MT
Transcript : Adaptimmune Therapeutics plc - Analyst/Investor Day
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
MT
Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated
AQ
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading
MT
Adaptimmune Therapeutics Says Unit Gets Termination Notice for Strategic Collaboration With Genentech
MT
Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated
NE
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower
MT
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Start Week Modestly Higher
MT
Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet
NE
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading
MT
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Friday Trading
MT
European Equities Traded in the US as American Depositary Receipts Ease Wednesday
MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ADAP Stock
  4. News Adaptimmune Therapeutics plc